Erratum: IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity (Scientific Reports (2016) 6 (20842) DOI: 10.1038/srep20842);IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Avnir, Yuval ^a   Watson, Corey T ^b,c   Glanville, Jacob ^d   Peterson, Eric C ^a   Tallarico, Aimee S ^a   Bennett, Andrew S ^a   Qin, Kun ^a   Fu, Ying ^a   Huang, Chiung Yu ^e   Beigel, John H ^f   Breden, Felix ^b   Zhu, Quan ^a   Marasco, Wayne A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b SIMON FRASER UNIVERSITY   (Canada)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ALLELE; B LYMPHOCYTE; GENE DOSAGE; GENE DUPLICATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H5N1); METABOLISM; REGULATORY SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC HYPERMUTATION;

ALLELES; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; GENE DOSAGE; GENE DUPLICATION; GENOTYPE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REGULATORY SEQUENCES, NUCLEIC ACID; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84958292295     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23876     Document Type: Erratum

References (39)

1. Franco, L. M. et al. Integrative genomic analysis of the human immune response to influenza vaccination. eLife 2, e00299, doi: 10.7554/eLife.00299 (2013).
2. Avnir, Y. et al. Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. PLoS pathogens 10, e1004103, doi: 10.1371/journal.ppat.1004103 (2014).
3. Watson, C. T. et al. Complete haplotype sequence of the human immunoglobulin heavy-chain variable, diversity, and joining genes and characterization of allelic and copy-number variation. American journal of human genetics 92, 530-546, doi: 10.1016/j. ajhg.2013.03.004 (2013).
4. Lefranc, M. P. Immunoglobulins: 25 years of immunoinformatics and IMGT-ONTOLOGY. Biomolecules 4, 1102-1139, doi: 10.3390/biom4041102 (2014).
5. Sasso, E. H., Willems van Dijk, K., Bull, A. P., Milner, E. C. A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles. The Journal of clinical investigation 91, 2358-2367, doi: 10.1172/JCI116468 (1993).
6. Milner, E. C., Hufnagle, W. O., Glas, A. M., Suzuki, I., Alexander, C. Polymorphism and utilization of human VH Genes. Annals of the New York Academy of Sciences 764, 50-61 (1995).
7. Lingwood, D. et al. Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489, 566-570, doi: 10.1038/nature11371 (2012).
8. Throsby, M. et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PloS one 3, e3942, doi: 10.1371/journal.pone.0003942 (2008).
9. Pappas, L. et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516, 418-422, doi: 10.1038/nature13764 (2014).
10. Wheatley, A. K. et al. H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem. Journal of immunology 195, 602-610, doi: 10.4049/jimmunol.1402835 (2015).
11. Williams, W. B. et al. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science, doi: 10.1126/science.aab1253 (2015).
12. Sasso, E. H., Johnson, T., Kipps, T. J. Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number. The Journal of clinical investigation 97, 2074-2080, doi: 10.1172/JCI118644 (1996).
13. Abecasis, G. R. et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073, doi: 10.1038/nature09534 (2010).
14. Glanville, J. et al. Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation. Proceedings of the National Academy of Sciences of the United States of America. 108, 20066-20071, doi: 10.1073/pnas.1107498108 (2011).
15. Whittle, J. R. et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. Journal of virology. 88, 4047-4057, doi: 10.1128/JVI.03422-13 (2014).
16. Roy, A. L., Sen, R., Roeder, R. G. Enhancer-promoter communication and transcriptional regulation of Igh. Trends in immunology 32, 532-539, doi: 10.1016/j.it.2011.06.012 (2011).
17. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome research 22, 1760-1774, doi: 10.1101/gr.135350.111 (2012).
18. Spender, L. C., Cornish, G. H., Sullivan, A., Farrell, P. J. Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. Journal of virology 76, 4919-4927 (2002).
19. Brady, G., Farrell, P. J. RUNX3-mediated repression of RUNX1 in B cells. Journal of cellular physiology 221, 283-287, doi: 10.1002/jcp.21880 (2009).
20. Watson, C. T., Breden, F. The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease. Genes and immunity 13, 363-373, doi: 10.1038/gene.2012.12 (2012).
21. Sui, J. et al. Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 52, 1003-1009, doi: 10.1093/cid/cir121 (2011).
22. Beigel, J. H., Voell, J., Huang, C. Y., Burbelo, P. D., Lane, H. C. Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. The Journal of infectious diseases. 200, 501-509, doi: 10.1086/599992 (2009).
23. Wyrzucki, A. et al. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody. Journal of virology. 88, 7083-7092, doi: 10.1128/JVI.00178-14 (2014).
24. Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850-856, doi: 10.1126/science.1205669 (2011).
25. Nakamura, G. et al. An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies. Cell host & microbe 14, 93-103, doi: 10.1016/j.chom.2013.06.004 (2013).
26. Sasso, E. H., Buckner, J. H., Suzuki, L. A. Ethnic differences in VH gene polymorphism. Annals of the New York Academy of Sciences 764, 72-73 (1995).
27. Shin, E. K. et al. Polymorphism of the human immunoglobulin variable region segment V1-4.1. Immunogenetics. 38, 304-306 (1993).
28. Andrews, S. F. et al. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response. Journal of virology 89, 3308-3317, doi: 10.1128/JVI.02871-14 (2015).
29. Henry Dunand, C. J. et al. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. The Journal of clinical investigation 125, 1255-1268, doi: 10.1172/JCI74374 (2015).
30. Krammer, F., Palese, P. Universal influenza virus vaccines: need for clinical trials. Nature immunology. 15, 3-5, doi: 10.1038/ni.2761 (2014).
31. Krammer, F., Pica, N., Hai, R., Margine, I., Palese, P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. Journal of virology 87, 6542-6550, doi: 10.1128/JVI.00641-13 (2013).
32. Wohlbold, T. J. et al. Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses. Vaccine 33, 3314-3321, doi: 10.1016/j.vaccine.2015.05.038 (2015).
33. Yassine, H. M. et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nature medicine 21, 1065-1070, doi: 10.1038/nm.3927 (2015).
34. Impagliazzo, A. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science, doi: 10.1126/science.aac7263 (2015).
35. Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nature structural & molecular biology 16, 265-273, doi: 10.1038/nsmb.1566 (2009).
36. Ippolito, G. C. et al. Antibody repertoires in humanized NOD-scid-IL2Rgamma(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PloS one 7, e35497, doi: 10.1371/journal.pone.0035497 (2012).
37. Potter, K. N., Li, Y., Mageed, R. A., Jefferis, R., Capra, J. D. Molecular characterization of the VH1-specific variable region determinants recognized by anti-idiotypic monoclonal antibodies G6 and G8. Scandinavian journal of immunology 50, 14-20 (1999).
38. Clark, R. A., Nauseef, W. M. In Current Protocols in Immunology (John Wiley & Sons, Inc., 2001).
39. Glanville, J. et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proceedings of the National Academy of Sciences of the United States of America 106, 20216-20221, doi: 10.1073/pnas.0909775106 (2009).